Lyophilised powder preserves compound integrity and allows precise reconstitution for controlled research protocols
Frequently Asked Questions Mild side effects include nausea, headache, lightheadedness, and injection-site pain/redness
Long answer: Like any supplement, misuse, excessive dosing, or poor product quality can create risk
DSIP contains no particularly sensitive residues and generally stores well in lyophilized form
GLP-1 class safety monitoring should include awareness of these important risks: Pancreatitis : Patients should promptly report severe abdominal pain, with or without vomiting Gallbladder disease : Report symptoms of biliary colic or cholecystitis Acute kidney injury : Maintain adequate hydration, especially if experiencing nausea/vomiting Hypoglycemia : Increased risk when used with insulin or sulfonylureas Suicidal ideation : For patients using Wegovy or Zepbound, monitor for mood changes Patients should be counseled to report any neck swelling, difficulty swallowing, persistent hoarseness, or palpable thyroid nodules, as these warrant evaluation regardless of GLP-1 use
But low rates of adherence mean that these too, are not often sustainable for long term weight management (5)
